Opinion
People are going to be
looking at abiraterone with
a low-dose prednisone, only
5mg of prednisone, add
it to ADT as being a new
potential standard of care.
Dr Oliver Sartor
on
the STAMPEDE trial
and prostate cancer
Conference
ASCO 2017
JOURNAL SCAN
Dabrafenib plus trametinib in patients
with BRAF(V600)-mutant melanoma
brain metastases (COMBI-MB)
Risks of breast, ovarian, and
contralateral breast cancer for BRCA1-
and BRCA2-mutation carriers
Liquid biopsy analysis of FGFR3 and
PIK3CA hotspot mutations for disease
surveillance in bladder cancer
Expert
consensus on
de-escalating
and escalating
treatments
for early-stage
breast cancer
VOL. 1 • NO. 2 • 2017
OUR EXPERTS. YOUR PRACTICE.
ISSN 2207-869X